Healthy Male

12 registered clinical trials studyying Healthy Male.

Status	Trial	Sponsor	Phase
Completed	A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants NCT06194500	Eli Lilly and Company	Phase 1
Completed	Phase I Trial of Envafolimab for Healthy Male Subjects NCT05849311	3D Medicines (Sichuan) Co., Ltd.	Phase 1
Completed	A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and NCT06105255	InventisBio Co., Ltd	Phase 1
Completed	Food Effect Study of IDX-1197 in Healthy Subjects NCT05202912	Idience Co., Ltd.	Phase 1
Completed	Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects NCT04828265	NGM Biopharmaceuticals, Inc	Phase 1
Completed	A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects NCT04135898	Shanghai Institute Of Biological Products	Phase 1
Completed	Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers NCT03674060	Samyang Biopharmaceuticals Corporation	Phase 1
Completed	Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteer NCT03208218	Samyang Biopharmaceuticals Corporation	Phase 1
Completed	To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With C NCT02395926	Hyundai Pharmaceutical Co., LTD.	Phase 1
Completed	Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200m NCT02395913	Hyundai Pharmaceutical Co., LTD.	Phase 1
Completed	A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunt NCT01651234	Green Cross Corporation	Phase 1
Terminated	Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Hea NCT01359618	AstraZeneca	Phase 1